Targeting reactive oxygen species by edaravone inhalation in a rat hyperoxic lung injury model: Role of inflammasome

Undersea and Hyperbaric Medicine

Volumn 40, Issue 6, 2013, Pages 505-511

  Wang, Chen ^a   Ye, Zhouheng ^b   Zheng, Juan ^b   Liu, Kan ^b   Sun, Xuejun ^b   Tao, Hengyi ^b,c   Liu, Wenwu ^b  

^a HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CELL RECEPTOR; DRUG DERIVATIVE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MALONALDEHYDE; NOD LIKE RECEPTOR 3, RAT; NOD-LIKE RECEPTOR 3, RAT; PHENAZONE; PHENYLMETHYLPYRAZOLONE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL; APOPTOSIS; ARTICLE; BODY WATER; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; HYPERBARIC OXYGEN; HYPEROXIA; LUNG; LUNG INJURY; LUNG LAVAGE; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; ANTIPYRINE; APOPTOSIS; BODY WATER; BRONCHOALVEOLAR LAVAGE FLUID; CASPASE 1; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; HYPERBARIC OXYGENATION; HYPEROXIA; INTERLEUKIN-18; INTERLEUKIN-1BETA; LUNG; LUNG INJURY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84891841444     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Clark JM, Lambertsen CJ. Pulmonary oxygen toxicity: a review. Pharmacol Rev. 1971;23(2):37-133.
2. Clark JM, Thom SR. Oxygen under pressure. In: Bennett and Elliott's Physiology and Medicine of Diving, edited by Brubakk AO and Newman TS. Flagstaff, AZ: Best Publishing, 2003.
3. Fisher AB, Forman HJ, Glass M. Mechanisms of pulmonary oxygen toxicity. Lung. 1984;162(5):255-9.
4. Higashi Y, Jitsuiki D, Chayama K, et al. Edaravone (3-methyl-1-phenyl-2- pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2006;1(1):85-93.
5. Feng S, Yang Q, Liu M, et al. Edaravone for acute ischemic stroke. Cochrane Database Syst Rev. 2011;12: CD007230.
6. Lamkanfi M, Dixit VM. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev. 2009; 227(1): 95-105.
7. Jin C, Flavell RA. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol. 2010; 30(5):628-31.
8. Franchi L, Eigenbrod T, Muñoz-Planillo R, et al. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10(3):241-7.
9. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002; 10(2):417-26.
10. Mariathasan S, Weiss DS, Newton K, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006;440(7081):228-32.
11. Carnesecchi S, Deffert C, Pagano A, et al. NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med. 2009;180(10): 972-81.
12. Ping Z, Liu W, Kang Z, et al. Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res. 2010;1343: 178-85
13. Hu J, Luo CX, Chu WH, et al. 20-Hydroxyecdysone protects against oxidative stress-induced neuronal injury by scavenging free radicals and modulating NF-κB and JNK pathways. PLoS One. 2012; 7(12): e50764.
14. Liu WH, Liu JJ, Wu J, et al. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PLoS One. 2013;8(1):e55487.
15. Gerschman D, Gilbert DL, Nye SW, et al. Oxygen poisoning and X irradiation: a mechanism in common. Science 1954;119(3097):623-625.
16. Carvalho CRR, Schettino GPP, Maranhao B, et al. Hyperoxia and lung disease. Curr Opin Pulm Med 1998;4(5): 300-304
17. Brigham KL. Role of free radicals and lung injury. Chest 1986; 89(6):859-863.
18. Cho HY, van Houten B, Wang X, et al. Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice. Antioxid Redox Signal. 2012;17(8):1066-82.
19. Faller S, Spassov SG, Zimmermann KK, et al. Hydrogen sulfide prevents hyperoxia-induced lung injury by downregulating reactive oxygen species formation and angiopoietin-2 release. Curr Pharm Des. 2013;19(15):2715-21.
20. Birrell MA, Eltom S. The role of the NLRP3 inflammation in the pathogenesis of airway disease. Pharmacol Ther. 2011;130(3):364-70.
21. Kolliputi N, Shaik RS, Waxman AB. The inflammation mediates hyperoxia-induced alveolar cell permeability. J Immunol. 2010;184(10):5819-26.
22. Kolliputi N, Galam L, Parthasarathy PT, et al. NALP-3 inflammasome silencing attenuates ceramide induced transepithelial permeability. J Cell Physiol. 2012; 227(9): 3310-6.
23. Pagano A, Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced lung injury. Ann N Y Acad Sci. 2003; 1010:405-16.
24. Jin Y, Tanaka A, Choi AM, et al. Autophagic proteins: new facets of the oxygen paradox. Autophagy. 2012; 8(3):426-8.
25. Otomo E, Tohgi H, Kogure K, et al. Clinical efficacy of a free radical scavenger, MCI-186, on acute cerebral infarction: Early phase II clinical trial. Ther Res. 1998;19:531-52.
26. Boost KA, Hoegl S, Hofstetter C, et al. Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia. Intensive Care Med. 2007;33(5):863-71.